Volume 36 Issue 4
Jul.  2020
Turn off MathJax
Article Contents
Article Navigation >  Journal of Nanjing University of traditional Chinese Medicine  > 2020  >  36(4): 567-572
LUDong-xue, CHENBing-yu, LIUFeng, SUNZhi-guang, SHANGWen-bin, ZHAOJuan, YUXi-zhong, YANJing. Discussion on Clinical Application of Bitter-Cold Medicine Based on Intestinal Flora[J]. Journal of Nanjing University of traditional Chinese Medicine, 2020, 36(4): 567-572.
Citation: LUDong-xue, CHENBing-yu, LIUFeng, SUNZhi-guang, SHANGWen-bin, ZHAOJuan, YUXi-zhong, YANJing. Discussion on Clinical Application of Bitter-Cold Medicine Based on Intestinal Flora[J]. Journal of Nanjing University of traditional Chinese Medicine, 2020, 36(4): 567-572.
shu

Discussion on Clinical Application of Bitter-Cold Medicine Based on Intestinal Flora

  • 1.

    The First School of Clinical Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China

  • 2.

    The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210017, China

  • 3.

    Department of Orthopedics and Traumatology, Nanjing Pukou Hospital of TCM, Nanjing, 210031, China

  • Publish Date: 2020-07-10
    Abstract
  • Bitter-cold medicine is commonly used in clinical practice and is widely used in internal medicine， surgery， gynecology， and pediatrics diseases. The homeostasis and imbalance of intestinal flora are the internal factors for curing and causing diseases. Previous researches on the clinical application of bitter-cold medicine have mostly focused on the basic research of gastrointestinal motility and hormones， No in-depth research and elaboration have been reported on the intestinal flora. From the microscopics of the structure proportion and distribution of intestinal flora， We expound the function restore of spleen and stomach by bitter-cold medicine， further prove the importance of intestinal flora in treating digestive diseases and provide more theoretical basis for clinical practices and basic experiments.

     

    • FullText(HTML)
  • loading
    • References(52)
  • [1]
    JEON YJ， LEE JS， CHO YR，et al. Banha-sasim-tang improves gastrointestinal function in loperamide-induced functional dyspepsia mouse model[J]. J Ethnopharmacol， 2019， 238：11834.
    [2]
    XIA ZA， ZHANG CH， DU YH， et al. The effect of traditional Chinese medicine Zhike-Houpu herbal pair on depressive behaviors and hippocampal serotonin 1A receptors in rats after chronic unpredictable mild stress[J]. Psych Med，2019，81(1)：100-109.
    [3]
    韩光耀，毕潇，余飞，等.中药黄连对鲢鱼消化酶和去毒酶活力及抗MC-LR作用的影响[J].安徽农业科学，2016，44(10):144-147.
    [4]
    杨茂艺，胡志鹏，岳仁宋，等.黄连不同剂型剂量对T2DM大鼠胃肠动力和胃肠激素的调控影响研究[J].中药药理与临床，2018，34(4):114-117.
    [5]
    王伟涛，孙伟正.血证论治[J].中国中医急症，2006(12):1364-1365.
    [6]
    刘金涛，李梦琳，陈子杰，等.《素问·脏气法时论》五脏苦欲补泻理论探析[J].中华中医药杂志，2019，34(7):2905-2908.
    [7]
    SENDER R， FUCHS S， MILO R. Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans[J]. Cell， 2016，164(3):337-340.
    [8]
    KAU AL， AHERN PP， GRIFFIN NW， et al. Human nutrition， the gut microbiome and the immune system[J]. Nature，2011，474(7351):327-336.
    [9]
    SHIN NR， WHON TW， BAE JW. Proteobacteria: Microbial signature of dysbiosis in gut microbiota[J]. Trends Biotechnol， 2015，33(9):496-503.
    [10]
    FLINT HJ， SCOTT KP， LOUIS P， et al. The role of the gut microbiota in nutrition and health[J]. Nat Rev Gastroenterol Hepatol， 2012， 9(10):577-589.
    [11]
    JANDHYALA SM， TALUKDAR R， SUBRAMANYAM C， et al. Role of the normal gut microbiota[J]. World J Gastroenterol， 2015，21(29): 8787-803.
    [12]
    CARROLL IM， RINGEL KULKA T， SIDDLE JP， et al. Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome[J]. Neurogastroenterol Motil，2012，24(6):521-530.
    [13]
    FRANK DN， ST AMAND AL， FELDMAN RA， et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases[J]. P Natl Acad Sci USA， 2007，104(34):13780-13785.
    [14]
    TREMAROLI V， BACKHED F. Functional interactions between the gut microbiota and host metabolism[J]. Nature，2012，489(7415):242-249.
    [15]
    STOCK J. Gut microbiota: An environmental risk factor for cardiovascular disease[J]. Atherosclerosis，2013，229(2):440-442.
    [16]
    SANDRA C.Intestinal barriers protect against disease[J]. Science， 2018， 359(6380):1097-1098.
    [17]
    刘颖，韩宪忠，徐美玲，等.黄连解毒汤联合水飞蓟宾胶囊对湿热蕴结型非酒精性脂肪性肝炎患者的治疗效果观察[J].中国中医基础医学杂志，2018， 24(9): 1258-1261.
    [18]
    YE XS， FENG YB， TONG Y， et al. Hepatoprotective effects of Coptidis rhizoma aqueous extract on carbon tetrachloride-induced acute liver hepatotoxicity in rats[J]. J Ethnopharmacol，2009，124(1):130-136.
    [19]
    陈阳，崔波，范燕豪，等.葛根芩连汤中各成分在正常与大肠湿热证模型大鼠的肠吸收差异研究[J].中国中药杂志，2020，45(1):169-178.
    [20]
    ZHANG YL， CAI LT， QI JY， et al. Gut microbiota contributes to the distinction between two traditional Chinese medicine syndromes of ulcerative colitis[J].World J Gastroenterol， 2019， 25(25): 3242-3255.
    [21]
    陈韵如.溃疡性结肠炎脾胃湿热证的微生态研究[D].广州: 广州中医药大学，2010．
    [22]
    DUPONT HL. Evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets[J]. Aliment Pharmacol Ther， 2014， 39(10):1033-1042.
    [23]
    CARROLL IM， RINGEL-KULKA T， SIDDLE JP， et al. Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome[J]. Neurogastroenterol Motil， 2012， 24(6):521-530.
    [24]
    WANG JF， ZHANG W， CHEN S， et al. Gut microbial modulation in the treatment of chemotherapy-induced diarrhea with Shenzhu Capsule[J]. BMC Complement Altern Med， 2019，19(1):126.
    [25]
    GAO ZL， WU Q， ZHAO X， et al. New insights into the mechanisms of Chinese herbal products on diabetes: A focus on the "bacteria-mucosal immunity-inflammation-diabetes" axis[J]. J Immunol Res， 2017， 2017:1813086.
    [26]
    JIANG HY， LIN ZX， ZHANG YH， et al. Altered fecal microbiota composition in patients with major depressive disorder[J]. Brain Behav Immun， 2015， 48:186-194.
    [27]
    刘佳琳. 肠道菌群介导的栀子豉汤抗抑郁作用及配伍机制研究[D].上海：中国人民解放军海军军医大学，2019.
    [28]
    周梦玲，李婷，倪敬年，等.帕金森病肠道菌群与中医证候的相关性研究[J].中华中医药杂志，2019，34(5):2274-2278.
    [29]
    水冰洁，温成平，范永升，等.解毒祛瘀滋阴方对系统性红斑狼疮小鼠肠道菌群的调节作用[J].中华中医药杂志，2015，30(7):2464-2469.
    [30]
    XIE WD， GU DY， LI JN， et al. Effects and action mechanisms of berberine and rhizoma coptidis on gut microbes and obesity in high fat diet fed C57BL/6J mice[J]. PLoS ONE， 2011， 6(9): e24520.
    [31]
    CUI H， CAI Y， WANG L， et al. Berberine regulates Treg/Th17 balance to treat ulcerative colitis through modulating the gut microbiota in the colon[J]. Front Pharmacol， 2018，9:571.
    [32]
    徐航宇. 黄芩汤对溃疡性结肠炎小鼠肠道菌群的影响及肠黏膜屏障的保护作用机制研究[D].北京：中国中医科学院，2018.
    [33]
    刘昌顺. 葛根芩连汤与感染性腹泻小型猪肠道菌群相互作用的研究[D].广州：南方医科大学，2019.
    [34]
    周霖，岑泳欣，王立生，等.小檗碱对肠易激综合征大鼠肠道菌群的影响[J].中国微生态学杂志，2018，30(7):772-776.
    [35]
    张园园，严君君，张培，等.黄连素调节肠道菌群减轻非酒精性脂肪性肝病肝脏炎症的实验研究[J].胃肠病学，2018，23(4):209-215.
    [36]
    HE K， HU Y， MA H， et al.Rhizoma Coptidis alkaloids alleviate hyperlipidemia in B6 mice by modulating gut microbiota and bile acid pathways[J]. Biochim Biophys Acta， 2016， 1862(9):1696-1709.
    [37]
    ZHANG CH， SHENG JQ， SARSAIYA S，et al.The anti-diabetic activities， gut microbiota composition， the anti-inflammatory effects of Scutellaria-coptis herb couple against insulin resistance-model of diabetes involving the toll-like receptor 4 signaling pathway[J]. J Ethnopharmacol， 2019， 237:202-214.
    [38]
    ZHAO L， CEN F， TIAN F， et al. Combination treatment with quercetin and resveratrol attenuates high fat diet-induced obesity and associated inflammation in rats via the AMPKα1/SIRT1 signaling pathway[J]. Exper Ther Med，2017，14(6):5942-5948.
    [39]
    杨旭，岳仁宋，徐萌，等.探讨糖尿病胃轻瘫大鼠肠道菌群失衡致免疫功能失调的机制研究及半夏泻心汤的干预作用[J].中药药理与临床，2019，35(2):17-21.
    [40]
    张静. 基于“脑-肠-肠道菌群”轴的银杏酮酯和多奈哌齐治疗阿尔茨海默病联用增效作用及机理研究[D].南京：南京中医药大学，2019.
    [41]
    吴梦雨. 比较生姜泻心汤与黄芩汤防治伊立替康所致小鼠腹泻的研究[D].北京：北京中医药大学，2019.
    [42]
    樊逸夫. 中药解毒颗粒对晚期肝癌患者肠道菌群的影响[D].上海：中国人民解放军海军军医大学，2018.
    [43]
    LYU J， JIA Y， LI J， et al.Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment[J].Cell Death Dis， 2019，10(6):415.
    [44]
    宋姗姗. 黄芩苷对小鼠肠道菌群的影响[D].广州：广州中医药大学，2010.
    [45]
    罗海燕，宋姗姗，黄暨生，等.黄芩苷对小鼠肠道菌群影响的量-时规律观察[J].中国医药指南，2010，8(32):42-43，49.
    [46]
    邱赛红，孙必强，李磊，等.常用苦寒药过量使用对胃黏膜屏障功能影响的实验研究[J].中国医药导刊，2007(2):140-142.
    [47]
    罗海华，董姝，周红，等.黄连解毒汤对小鼠肠黏膜组织结构的影响[J].长春中医药大学学报，2009，25(1):14-15.
    [48]
    吕宁.泻下药/补益药与肠道菌群相互作用的初步研究[D].郑州：河南中医药大学，2018.
    [49]
    DREESSEN M， LEMLI J. Studies in the field of drugs containing anthraquinone derivatives. The metabolism of cascarosides by intestinal bacteria[J]. Pharmaceutica acta Helvetiae，1988，63(9/10):278-279.
    [50]
    CLAESSON MJ， CUSACK S， O' SULLIVAN O， et al. Composition， variability， and temporal stability of the intestinal microbiota of the elderly[J]. P Natl Acad Sci USA， 2011， 108(S1): 4586-4545.
    [51]
    DETHLEFSEN L， RELMAN DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation[J]. P Natl Acad Sci USA， 2011， 108(S1): 4554-4561.
    [52]
    吴梦雨. 比较生姜泻心汤与黄芩汤防治伊立替康所致小鼠腹泻的研究[D].北京：北京中医药大学，2019.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (725) PDF downloads(512) Cited by()
    Proportional views
    Related

    Copyright © Journal of Nanjing University of traditional Chinese Medicine

    Sponsored by：Nanjing University of traditional Chinese MedicineAddress：No.138 xianlin Avenue, Qixia District, Nanjing cityChina Pos：210023

    Tel：025-85811935Email：xb@njucm.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return